PBH Prestige Consumer Healthcare Inc.
Stock · NYSE · United States · Healthcare · US74112D1019
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Prestige Consumer Healthcare Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
42.98 USD
-3.02%
52-week range
41.77 – 71.07
Dividend yield—
Market cap2.0B
NowoTrade score
42 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:54. Information, not advice.
Results
Next results
04 Feb 2027
in 88 days · 08:00 · estimate 1.23
Last results
1.13 vs 1.07 estimated
05 Nov 2026 · Beat +5.3%
Beat the estimate
6 of 12
5 missed · 1 in line · 2 beats in a row
Average surprise
-0.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 1.23 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 1.07 | 1.13 | +5.3% | Beat |
| 06 Aug 2026 06:00 | 0.88 | 0.98 | +12.0% | Beat |
| 13 May 2026 16:00 | 1.39 | 1.23 | -11.5% | Miss |
| 05 Feb 2026 06:00 | 1.16 | 1.14 | -1.4% | Miss |
| 06 Nov 2025 06:00 | 0.97 | 0.86 | -11.3% | Miss |
| 07 Aug 2025 06:00 | 0.99 | 0.95 | -4.2% | Miss |
| 08 May 2025 06:00 | 1.29 | 1.32 | +2.2% | Beat |
| 06 Feb 2025 06:00 | 1.16 | 1.22 | +5.4% | Beat |
| 07 Nov 2024 06:00 | 1.08 | 1.09 | +0.5% | In line |
| 08 Aug 2024 06:00 | 0.86 | 0.90 | +4.7% | Beat |
| 14 May 2024 17:00 | 1.14 | 1.02 | -10.5% | Miss |
| 08 Feb 2024 06:00 | 1.04 | 1.06 | +1.8% | Beat |
| 02 Nov 2023 06:00 | 1.07 | 1.07 | +0.3% | In line |
| 03 Aug 2023 06:00 | 1.01 | 1.06 | +5.0% | Beat |
| 04 May 2023 06:00 | 1.04 | 1.07 | +2.9% | Beat |
| 02 Feb 2023 06:00 | 1.01 | 1.04 | +2.8% | Beat |
| 03 Nov 2022 06:00 | 1.00 | 1.02 | +1.8% | Beat |
| 04 Aug 2022 06:00 | 1.04 | 1.09 | +5.0% | Beat |
| 05 May 2022 16:00 | 0.89 | 0.91 | +2.6% | Beat |
| 03 Feb 2022 06:00 | 0.88 | 0.99 | +12.1% | Beat |
| 04 Nov 2021 06:00 | 0.99 | 1.02 | +3.4% | Beat |
| 05 Aug 2021 06:00 | 0.87 | 1.14 | +31.5% | Beat |
| 06 May 2021 06:00 | 0.78 | 0.79 | +0.7% | In line |
| 04 Feb 2021 06:00 | 0.77 | 0.81 | +5.6% | Beat |
| 05 Nov 2020 06:00 | 0.72 | 0.78 | +8.8% | Beat |
| 06 Aug 2020 06:00 | 0.70 | 0.86 | +22.9% | Beat |
| 07 May 2020 07:00 | 0.74 | 0.82 | +11.5% | Beat |
| 06 Feb 2020 06:00 | 0.75 | 0.81 | +8.0% | Beat |
| 31 Oct 2019 06:00 | 0.66 | 0.68 | +3.7% | Beat |
| 01 Aug 2019 06:00 | 0.64 | 0.65 | +2.2% | Beat |
| 09 May 2019 06:00 | 0.70 | 0.72 | +2.3% | Beat |
| 07 Feb 2019 06:00 | 0.72 | 0.73 | +1.1% | Beat |
| 01 Nov 2018 06:00 | 0.63 | 0.65 | +3.5% | Beat |
| 02 Aug 2018 06:00 | 0.67 | 0.68 | +2.1% | Beat |
| 10 May 2018 06:00 | 0.61 | 0.62 | +1.6% | Beat |
| 01 Feb 2018 06:00 | 0.70 | 0.70 | -0.2% | In line |
| 02 Nov 2017 06:00 | 0.66 | 0.61 | -8.0% | Miss |
| 03 Aug 2017 06:00 | 0.64 | 0.66 | +3.7% | Beat |
| 11 May 2017 06:00 | 0.55 | 0.54 | -1.5% | Miss |
| 02 Feb 2017 06:00 | 0.56 | 0.61 | +9.5% | Beat |
| 03 Nov 2016 06:00 | 0.61 | 0.63 | +2.8% | Beat |
| 04 Aug 2016 06:00 | 0.54 | 0.59 | +8.7% | Beat |
| 12 May 2016 06:00 | 0.49 | 0.52 | +6.1% | Beat |
| 04 Feb 2016 06:00 | 0.49 | 0.53 | +8.6% | Beat |
| 05 Nov 2015 06:00 | 0.57 | 0.60 | +5.6% | Beat |
| 06 Aug 2015 06:00 | 0.49 | 0.52 | +7.0% | Beat |
| 14 May 2015 06:00 | 0.45 | 0.47 | +4.0% | Beat |
| 05 Feb 2015 06:00 | 0.41 | 0.48 | +17.8% | Beat |
| 06 Nov 2014 06:00 | 0.45 | 0.50 | +11.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 1.1B | -4.3% | 190.3M | 17.5% | 3.91 | -8.9% | 246.4M |
| 2025 | 1.1B | +1.1% | 214.6M | 18.9% | 4.29 | +2.9% | 243.3M |
| 2024 | 1.1B | -0.2% | 209.3M | 18.6% | 4.17 | +352.7% | 239.4M |
| 2023 | 1.1B | — | -82.3M | -7.3% | -1.65 | — | 221.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 27 May 2025 – 30 May 2025 | 86.62 | 86.76 | 83.82 | 85.67 | -0.09% | 1,191,300 | |
| 19 May 2025 – 23 May 2025 | 88.88 | 89.24 | 83.86 | 85.75 | -3.75% | 2,009,600 | |
| 12 May 2025 – 16 May 2025 | 88.39 | 89.37 | 85.40 | 89.09 | +2.05% | 1,937,700 | |
| 05 May 2025 – 09 May 2025 | 84.16 | 88.00 | 80.62 | 87.30 | +3.69% | 2,327,900 | |
| 28 Apr 2025 – 02 May 2025 | 80.73 | 84.90 | 79.32 | 84.19 | +4.53% | 1,787,300 | |
| 21 Apr 2025 – 25 Apr 2025 | 80.12 | 82.88 | 78.05 | 80.54 | +0.32% | 1,446,200 | |
| 14 Apr 2025 – 17 Apr 2025 | 82.78 | 83.07 | 79.44 | 80.28 | -2.24% | 1,328,100 | |
| 07 Apr 2025 – 11 Apr 2025 | 80.20 | 84.24 | 77.66 | 82.12 | -0.88% | 2,562,000 | |
| 31 Mar 2025 – 04 Apr 2025 | 84.31 | 88.55 | 82.29 | 82.85 | -2.63% | 2,608,300 | |
| 24 Mar 2025 – 28 Mar 2025 | 84.50 | 86.40 | 84.08 | 85.09 | +1.05% | 1,532,700 | |
| 17 Mar 2025 – 21 Mar 2025 | 83.51 | 85.39 | 82.99 | 84.21 | +0.62% | 1,596,700 | |
| 10 Mar 2025 – 14 Mar 2025 | 88.01 | 90.04 | 81.78 | 83.69 | -5.99% | 1,909,600 | |
| 03 Mar 2025 – 07 Mar 2025 | 84.95 | 89.65 | 83.95 | 89.02 | +5.04% | 2,105,000 | |
| 24 Feb 2025 – 28 Feb 2025 | 84.89 | 87.80 | 83.12 | 84.75 | +0.14% | 1,685,300 | |
| 18 Feb 2025 – 21 Feb 2025 | 85.81 | 86.51 | 84.00 | 84.63 | -1.59% | 1,089,700 | |
| 10 Feb 2025 – 14 Feb 2025 | 86.81 | 87.94 | 83.65 | 86.00 | -1.15% | 1,688,200 | |
| 03 Feb 2025 – 07 Feb 2025 | 76.28 | 88.36 | 74.35 | 87.00 | +13.33% | 2,342,100 | |
| 27 Jan 2025 – 31 Jan 2025 | 77.45 | 80.23 | 76.22 | 76.77 | +0.12% | 1,270,600 | |
| 21 Jan 2025 – 24 Jan 2025 | 79.13 | 80.00 | 76.01 | 76.68 | -2.42% | 1,132,300 | |
| 13 Jan 2025 – 17 Jan 2025 | 73.48 | 79.20 | 73.48 | 78.58 | +6.19% | 1,227,300 | |
| 06 Jan 2025 – 10 Jan 2025 | 76.47 | 76.98 | 72.65 | 74.00 | -3.75% | 1,313,500 | |
| 30 Dec 2024 – 03 Jan 2025 | 77.97 | 78.98 | 76.19 | 76.88 | -2.00% | 1,085,600 | |
| 23 Dec 2024 – 27 Dec 2024 | 79.23 | 79.71 | 77.78 | 78.45 | -0.34% | 521,300 | |
| 16 Dec 2024 – 20 Dec 2024 | 82.52 | 83.67 | 77.83 | 78.72 | -4.35% | 1,759,900 | |
| 09 Dec 2024 – 13 Dec 2024 | 83.62 | 84.98 | 81.81 | 82.30 | -2.41% | 1,382,400 |
Page 4 of 11
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Prestige Consumer Healthcare Q2 Earnings Call Highlights (opens in a new tab) MarketBeat · 08 Nov 2026 03:14
- Prestige Consumer Healthcare Inc. (PBH) Q2 2027 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 07 Nov 2026 18:24
- Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $70 (opens in a new tab) Benzinga · 06 Nov 2026 15:21
- Prestige Consumer Healthcare (PBH) Stock Dropped, So What Is Driving Attention Now? (opens in a new tab) Simply Wall St. · 06 Nov 2026 15:15
- Prestige Consumer Healthcare Inc (PBH) (Q2 2027) Earnings Call Highlights: Revenue Surges 23% ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 09:11
- Prestige Healthcare (PBH) Q2 2027 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:45
- Prestige Consumer Healthcare Stock In Focus After Revenue Rose But Profit Fell (opens in a new tab) Simply Wall St. · 05 Nov 2026 14:18
- Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 05 Nov 2026 13:30
- Prestige Consumer Healthcare Inc. Reports Q2 Revenue of $336.3 million and Updates Fiscal 2027 Outlook (opens in a new tab) Fintel · 05 Nov 2026 12:23
- Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates (opens in a new tab) Zacks · 05 Nov 2026 11:35
- Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot (opens in a new tab) Associated Press · 05 Nov 2026 11:16
- Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results (opens in a new tab) 05 Nov 2026 11:00
- Prestige Consumer Q2 2027 Earnings Call Transcript (opens in a new tab) Benzinga · 05 Nov 2026 10:34
- Prestige Consumer Lowers FY2027 Adj EPS Guidance from $4.55-$4.65 to $4.48-$4.55 vs $4.58 Est; Lowers FY2027 Sales Guidance from $1.290B-$1.315B to $1.280B-$1.290B vs $1.298B Est (opens in a new tab) Benzinga · 05 Nov 2026 07:03
- Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? (opens in a new tab) Zacks · 15 Oct 2026 14:23
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 44.32 USD
- Market cap
- 2.0B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 8.9 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 12.6 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 15.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Heavy debt: net debt is 6.0× EBITDA
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 13.27× | Good | 30.65× |
| P/E (forward) | 8.43× | Good | 14.89× |
| Price / book | 1.05× | Good | 3.8× |
| Price / sales | 1.75× | Good | 3.19× |
| EV / EBITDA | 11.93× | Fair | 12.61× |
| Free cash flow yield | 7.2% | Good | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 54.9% | Good | 58.6% |
| Operating margin | 24% | Good | 7.6% |
| Net margin | 13.3% | Good | 2.7% |
| Return on equity | 8.2% | Fair | 5.7% |
| Return on assets | 4.7% | Fair | 3.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -1.2% | Weak | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.09× | Fair | 0.48× |
| Net debt / EBITDA | 6.03× | Weak | 1.6× |
| Interest cover | 7.31× | Fair | 2.65× |
| Current ratio | 2.92× | Good | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow PBH and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.